SGS plans to open its second Life Science Services facility in Mumbai, India, which is expected to be fully operational by mid-2012. This investment will establish a dedicated GMP lab to provide a range of analytical development and quality control testing services. It includes a lab for new or expanded services in stability testing, extractables and leachables, analytical chemistry, and microbiology. SGS will also invest in the latest generation of mass spectrometers and stability chambers to increase testing and sample storage capacities. The 15,000-sq.-ft. facility will initially employ 20 staff and as many as 90 additional positions in the next five years.

“This investment is part of the three-year growth plan for SGS India and the Life Science Services division,” said Anne Hays, executive vice president for SGS Life Science Services “With the growth of the pharmaceutical market in India, and specifically Mumbai, SGS takes this initiative to be in physically closer to our customers, while maintaining the quality we deliver, building our service offerings, and expanding our global network of laboratories.”